Correlation Between Allarity Therapeutics and Regen BioPharma

Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Allarity Therapeutics and Regen BioPharma, you can compare the effects of market volatilities on Allarity Therapeutics and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Regen BioPharma.

Diversification Opportunities for Allarity Therapeutics and Regen BioPharma

0.74

Correlation Coefficient

Allarity Therapeutics  Regen BioPharma

Poor diversification

The 3 months correlation between Allarity and Regen is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Regen BioPharma go up and down completely randomly.

Pair Corralation between Allarity Therapeutics and Regen BioPharma

Given the investment horizon of 90 days Allarity Therapeutics is expected to generate 18.16 times less return on investment than Regen BioPharma. But when comparing it to its historical volatility, Allarity Therapeutics is 3.64 times less risky than Regen BioPharma. It trades about 0.01 of its potential returns per unit of risk. Regen BioPharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  7.71  in Regen BioPharma on October 10, 2024 and sell it today you would lose (0.71) from holding Regen BioPharma or give up 9.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Allarity Therapeutics  vs.  Regen BioPharma

Allarity Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Allarity Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's essential indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Regen BioPharma

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Allarity Therapeutics and Regen BioPharma

The main advantage of trading using opposite Allarity Therapeutics and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.

The idea behind Allarity Therapeutics and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.